One study has demonstrated that GATA-2 is necessary for non-small cell lung cancer, via regulation of the proteasome, IL-1/NFκB signaling and Rho-signaling pathways, thereby providing enhanced proliferation for RAS-mutation. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.